159 related articles for article (PubMed ID: 352919)
1. Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.
Vladutiu AO
Immunol Commun; 1978; 7(4):371-82. PubMed ID: 352919
[TBL] [Abstract][Full Text] [Related]
2. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: its role in the pathogenesis of chronic type B hepatitis.
Chu CM; Shyu WC; Kuo RW; Liaw YF
Hepatology; 1988; 8(3):712-7. PubMed ID: 3286466
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of HLA class 1 antigens on the hepatocytes of patients with chronic hepatitis B.
Manabe K; Yamada G; Nagashima H
Gastroenterol Jpn; 1986 Aug; 21(4):357-64. PubMed ID: 2429887
[TBL] [Abstract][Full Text] [Related]
4. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection.
Pignatelli M; Waters J; Brown D; Lever A; Iwarson S; Schaff Z; Gerety R; Thomas HC
Hepatology; 1986; 6(3):349-53. PubMed ID: 2423427
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
Karino Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
[TBL] [Abstract][Full Text] [Related]
6. T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection.
Alberti A; Realdi G; Bortolotti F; Rigoli AM
Gut; 1977 Dec; 18(12):1004-9. PubMed ID: 304824
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens in patients with various courses after hepatitis B virus infection.
van Hattum J; Schreuder GM; Schalm SW
Hepatology; 1987; 7(1):11-4. PubMed ID: 2433202
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection.
Alexander GJ; Nouri-Aria KT; Neuberger J; Bakhtiar M; Vogel W; Anderson MG; Magrin S; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S269-77. PubMed ID: 3110263
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection.
Montano L; Miescher GC; Goodall AH; Wiedmann KH; Janossy G; Thomas HC
Hepatology; 1982; 2(5):557-61. PubMed ID: 7118068
[TBL] [Abstract][Full Text] [Related]
10. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination.
Kacprzak-Bergman I; Nowakowska B
Arch Immunol Ther Exp (Warsz); 2005; 53(2):139-42. PubMed ID: 15928582
[TBL] [Abstract][Full Text] [Related]
11. T cell recognition of hepatitis B and C viral antigens.
Jung MC; Diepolder HM; Pape GR
Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
[TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.
Naumov NV; Mondelli M; Alexander GJ; Tedder RS; Eddleston AL; Williams R
Hepatology; 1984; 4(1):63-8. PubMed ID: 6607203
[TBL] [Abstract][Full Text] [Related]
13. In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens.
van den Oord JJ; de Vos R; Desmet VJ
Hepatology; 1986; 6(5):981-9. PubMed ID: 3530950
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
15. Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.
Eddleston AL; Williams R
Lancet; 1974 Dec; 2(7896):1543-5. PubMed ID: 4140983
[No Abstract] [Full Text] [Related]
16. Immunohistochemical investigation of hepatitis B virus associated antigens, HLA antigens and lymphocyte subsets in type B chronic hepatitis.
Aoyama K; Kojima T; Inoue K; Sasaki H
Gastroenterol Jpn; 1990 Feb; 25(1):41-53. PubMed ID: 2407598
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lymphocytes and elimination of rosette-inhibitory factor.
Dolen JG; Carter WA; Horoszewicz JS; Vladutiu AO; Leibowitz AI; Nolan JP
Am J Med; 1979 Jul; 67(1):127-31. PubMed ID: 313705
[TBL] [Abstract][Full Text] [Related]
18. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
19. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
20. Is modulation of HLA display by interferon important in preventing the development of the chronic carrier state of hepatitis B virus in adults?
Thomas HC; Pignatelli M
Gastroenterol Clin Biol; 1985 Apr; 9(4):287-9. PubMed ID: 2581841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
